Reuters logo
BRIEF-Epigenomics FY 2016 total revenue up by 102 pct to 4.2 mln euros
April 26, 2017 / 3:05 AM / in 6 months

BRIEF-Epigenomics FY 2016 total revenue up by 102 pct to 4.2 mln euros

April 26 (Reuters) - Epigenomics Ag

* Says in 2016, Epigenomics’ total revenue increased by 102 percent to 4.2 million euros

* Epigenomics - “level of 2016 product revenue was impacted by initial stocking effects from our commercialization partner post FDA approval”

* Says expects 2017 revenue to be broadly consistent with our 2016 product and licensing revenue

* Says expect EBITDA before share-based payment expenses for 2017 to be at a lower level than in 2016

* Says a range from EUR -12.0 to -13.5 million is assumed for 2017 EBITDA before share-based payment expenses

* Says based on business plan for 2017, we expect cash consumption in line with EBITDA guidance

* Says “beyond 2017, we may raise additional capital in 2017” Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below